Michael Klichinsky insider trades
Open-market stock purchases and sales by Michael Klichinsky, Chief Scientific Officer at Carisma Therapeutics Inc, from SEC Form 4 filings since Mar 7, 2023.
Companies traded
- CARM Carisma Therapeutics Inc: 4 sales, last Oct 7, 2025